Letrozole Arrow (Letrozole)

Letrozole works by selectively blocking the aromatase enzyme, which converts androgens into estrogens in peripheral tissues. By inhibiting this conversion, systemic estrogen levels fall, depriving estrogen‑dependent breast cancer cells of the hormonal stimulus needed for growth.

The dosage of Letrozole Arrow is determined by the prescribing clinician based on the patient’s clinical condition, treatment stage and tolerability. Physicians typically start with the standard recommended dose, but the exact amount and schedule must be individualized and written on the prescription.

Letrozole is classified as Pregnancy Category X, meaning it is contraindicated during pregnancy because it can cause fetal harm. It is also not recommended for breastfeeding mothers, as it may be excreted in milk and affect the infant. Women of child‑bearing potential must use effective contraception.

To order Letrozole Arrow, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Letrozole is a non‑steroidal aromatase inhibitor with high potency and a long half‑life, offering once‑daily dosing. Compared with other agents such as anastrozole or exemestane, letrozole often provides slightly greater estrogen suppression, though clinical choice depends on individual patient factors, tolerability and physician preference.

Letrozole Arrow tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Letrozole Arrow is taken orally as a tablet. The tablet should be swallowed whole with water, and it may be taken with or without food. Patients should follow the dosing instructions provided by their healthcare professional.

The most serious risks include significant bone loss leading to fractures, liver function abnormalities, and severe allergic reactions such as rash, angioedema or anaphylaxis. Patients should report any new bone pain, jaundice, or signs of hypersensitivity to their physician promptly.

Letrozole Arrow should not be used by pregnant or breastfeeding women, premenopausal patients, individuals with severe hepatic impairment, or anyone with a known hypersensitivity to letrozole or other aromatase inhibitors. Contraindications are outlined in the prescribing information and must be reviewed before initiation.